BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19632986)

  • 1. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors.
    Navarro G; Aymerich MS; Marcellino D; Cortés A; Casadó V; Mallol J; Canela EI; Agnati L; Woods AS; Fuxe K; Lluís C; Lanciego JL; Ferré S; Franco R
    J Biol Chem; 2009 Oct; 284(41):28058-28068. PubMed ID: 19632986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-mediated modulation of the quaternary structure and function of adenosine A2A-dopamine D2 receptor heteromers.
    Ferré S; Woods AS; Navarro G; Aymerich M; Lluís C; Franco R
    Curr Opin Pharmacol; 2010 Feb; 10(1):67-72. PubMed ID: 19896897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors.
    Woods AS; Marcellino D; Jackson SN; Franco R; Ferré S; Agnati LF; Fuxe K
    J Proteome Res; 2008 Aug; 7(8):3428-34. PubMed ID: 18590318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells.
    Cabello N; Gandía J; Bertarelli DC; Watanabe M; Lluís C; Franco R; Ferré S; Luján R; Ciruela F
    J Neurochem; 2009 Jun; 109(5):1497-507. PubMed ID: 19344374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
    Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
    Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular calcium levels determine differential modulation of allosteric interactions within G protein-coupled receptor heteromers.
    Navarro G; Aguinaga D; Moreno E; Hradsky J; Reddy PP; Cortés A; Mallol J; Casadó V; Mikhaylova M; Kreutz MR; Lluís C; Canela EI; McCormick PJ; Ferré S
    Chem Biol; 2014 Nov; 21(11):1546-56. PubMed ID: 25457181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
    J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
    Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
    Vidi PA; Chemel BR; Hu CD; Watts VJ
    Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.
    Soriano A; Ventura R; Molero A; Hoen R; Casadó V; Cortés A; Fanelli F; Albericio F; Lluís C; Franco R; Royo M
    J Med Chem; 2009 Sep; 52(18):5590-602. PubMed ID: 19711895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders.
    Ferré S; Ciruela F; Canals M; Marcellino D; Burgueno J; Casadó V; Hillion J; Torvinen M; Fanelli F; Benedetti Pd Pd; Goldberg SR; Bouvier M; Fuxe K; Agnati LF; Lluis C; Franco R; Woods A
    Parkinsonism Relat Disord; 2004 Jul; 10(5):265-71. PubMed ID: 15196504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R.
    Borroto-Escuela DO; Marcellino D; Narvaez M; Flajolet M; Heintz N; Agnati L; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Mar; 394(1):222-7. PubMed ID: 20197060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Gómez-Soler M; Corrales F; Marcellino D; Narvaez M; Frankowska M; Flajolet M; Heintz N; Agnati LF; Ciruela F; Fuxe K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):801-7. PubMed ID: 21040702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique.
    Gandia J; Galino J; Amaral OB; Soriano A; Lluís C; Franco R; Ciruela F
    FEBS Lett; 2008 Sep; 582(20):2979-84. PubMed ID: 18675812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.
    Beggiato S; Antonelli T; Tomasini MC; Borelli AC; Agnati LF; Tanganelli S; Fuxe K; Ferraro L
    Curr Protein Pept Sci; 2014; 15(7):673-80. PubMed ID: 25175458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors.
    Ciruela F; Burgueño J; Casadó V; Canals M; Marcellino D; Goldberg SR; Bader M; Fuxe K; Agnati LF; Lluis C; Franco R; Ferré S; Woods AS
    Anal Chem; 2004 Sep; 76(18):5354-63. PubMed ID: 15362892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.
    Navarro G; Carriba P; Gandía J; Ciruela F; Casadó V; Cortés A; Mallol J; Canela EI; Lluis C; Franco R
    ScientificWorldJournal; 2008 Oct; 8():1088-97. PubMed ID: 18956124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.
    Canals M; Marcellino D; Fanelli F; Ciruela F; de Benedetti P; Goldberg SR; Neve K; Fuxe K; Agnati LF; Woods AS; Ferré S; Lluis C; Bouvier M; Franco R
    J Biol Chem; 2003 Nov; 278(47):46741-9. PubMed ID: 12933819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R.
    Fernández-Dueñas V; Gómez-Soler M; Jacobson KA; Kumar ST; Fuxe K; Borroto-Escuela DO; Ciruela F
    J Neurochem; 2012 Nov; 123(3):373-84. PubMed ID: 22924752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.